Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02098811 · ClinicalTrials.gov registry record · NA
Evaluation of the Safety and Precursors of Efficacy
A NA study of Subcutaneous Fat, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02098811: Completed NA study of Subcutaneous Fat, sponsored by Cynosure.
NCT02098811 is a NA study of Subcutaneous Fat that has completed, run by Cynosure. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02098811, a NA study of Subcutaneous Fat, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate and compare the safety and pre-cursors of efficacy of a non-invasive 1064nm laser and 940nm diode, for the disruption of subcutaneous adipose tissue and skin tightening.
Primary Outcome
Biopsy of treated area will be obtained up to 6 months post treatment and will be histologically assessed for changes in adipocytes, collagen and surrounding tissue to determine effectiveness of device
Conditions Studied
Interventions
- DEVICE 1064nm Laser
- DEVICE 940nm Laser
Study Locations (1)
New York
- Aesthetic Pavilion - Staten Island
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT02098811 record still lists
NCT02098811 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Subcutaneous Fat appearing as the primary indexed condition, and to 2 interventions - of which 1064nm Laser is the first listed.
NCT02098811 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02098811 about?
NCT02098811 is a clinical study titled "Evaluation of the Safety and Precursors of Efficacy". The purpose of this study is to evaluate and compare the safety and pre-cursors of efficacy of a non-invasive 1064nm laser and 940nm diode, for the disruption of subcutaneous adipose tissue and skin tightening.
What is the current status of trial NCT02098811?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-06. Estimated completion is 2014-05.
What conditions does trial NCT02098811 study?
This clinical trial studies the following conditions: Subcutaneous Fat.
What interventions are being tested in trial NCT02098811?
The interventions under investigation include: 1064nm Laser (DEVICE), 940nm Laser (DEVICE).
Who is sponsoring clinical trial NCT02098811?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02098811 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Subcutaneous Fat
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02098811's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia